Editor's Note
Up to 4 million doses of the Johnson & Johnson (J&J) single-dose COVID-19 vaccine will be delivered to states, community health centers, and pharmacies next week, if the vaccine receives Emergency Use Authorization (EUA) from the Food & Drug Administration (FDA), the February 24 The Hill reports.
An FDA analysis released February 24 indicates the vaccine is safe and effective and meets requirements for an EUA. The FDA’s Vaccines and Related Biological Products Advisory Committee is set to meet on February 26 to consider whether to recommend an EUA.
What happens when a veteran perioperative leader walks away from…
The migration of surgical cases from inpatient settings to ambulatory…
In perioperative care, high-performing teams are critical to patient safety…